NEW YORK , June 7, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. ("Humana" or the "Company") (NYSE: HUM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NEWTOWN, Pa., June 06, 2025 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Humana Inc. (“Humana”) (NYSE: HUM), resulting from allegations of providing potentially misleading business information to the investing public.
NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. (“Humana” or the “Company”) (NYSE: HUM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
![]() HUM 2 months ago | Other | €0.77 Per Share |
![]() HUM 5 months ago | Other | €0.77 Per Share |
![]() HUM 8 months ago | Other | €0.77 Per Share |
![]() HUM 11 months ago | Other | €0.77 Per Share |
![]() HUM 27 Mar 2024 | Other | €0.77 Per Share |
30 Jul 2025 (51 Days) Date | | - Cons. EPS | - EPS |
29 Jul 2025 (50 Days) Date | | - Cons. EPS | - EPS |
22 Apr 2025 Date | | - Cons. EPS | - EPS |
23 Jan 2025 Date | | - Cons. EPS | - EPS |
30 Oct 2024 Date | | - Cons. EPS | - EPS |
![]() HUM 2 months ago | Other | €0.77 Per Share |
![]() HUM 5 months ago | Other | €0.77 Per Share |
![]() HUM 8 months ago | Other | €0.77 Per Share |
![]() HUM 11 months ago | Other | €0.77 Per Share |
![]() HUM 27 Mar 2024 | Other | €0.77 Per Share |
30 Jul 2025 (51 Days) Date | | - Cons. EPS | - EPS |
29 Jul 2025 (50 Days) Date | | - Cons. EPS | - EPS |
22 Apr 2025 Date | | - Cons. EPS | - EPS |
23 Jan 2025 Date | | - Cons. EPS | - EPS |
30 Oct 2024 Date | | - Cons. EPS | - EPS |
Medical - Healthcare Plans Industry | Healthcare Sector | Mr. James A. Rechtin M.B.A. CEO | XSTU Exchange | US4448591028 ISIN |
US Country | 65,680 Employees | 27 Jun 2025 Last Dividend | 1 Aug 1991 Last Split | 22 Jan 1993 IPO Date |
Humana Inc., with its array of subsidiaries, stands as a major provider of medical and specialty insurance products across the United States. Initially established in 1961 and undergoing a name change from Extendicare Inc. to Humana Inc. in April 1974, the company is ingrained in the fabric of U.S. healthcare, having its roots and headquarters in Louisville, Kentucky. The organization operates through two primary segments: Insurance and CenterWell, showcasing a broad spectrum of health-related services and insurance products. Its purpose is deeply intertwined with offering extensive insurance coverage and healthcare services, primarily targeting individuals, employee groups, and military personnel.
Humana Inc.’s range of products and services underscores its commitment to providing comprehensive healthcare and insurance solutions. Here is a breakdown of its key offerings: